Price $40.80 |
Market Cap
2.07B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
59.8
|
P/B
3.12
|
P/S
3.09
|
Dividend %
-
|
|
P/CF
72.9
|
P/FCF
32.4
|
Op. Cash Flow
62.7K
|
FCF
1.2
|
|
Op. Margin
5.10%
|
Net Margin
4.90%
|
ROE
5.70%
|
ROI
3.60%
|
|
ROA
3.30%
|
EPS Growth
37.40%
|
Current Ratio
2.8
|
Debt/Equity
63.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Veru Inc (VERU) | $2.17 | - | - | 85.7M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.46 | - | - | 42.8M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.65 | - | - | 24.3M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.72 | - | - | 4.6M | Strong Buy |
| Misonix, Inc. (MSON) | $10.20 | - | - | 91.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
